Reviva Pharmaceuticals (RVPH) EPS (2018 - 2026)
Reviva Pharmaceuticals (RVPH) EPS from Aug 31, 2018 to Mar 31, 2026. The TTM Reviva Pharmaceuticals (RVPH) EPS is -$3.44. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual EPS
Quarterly EPS
Reviva Pharmaceuticals (RVPH) EPS CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | -78.14% |
| 5 Years TTM | +56.49% |
Annual EPS change of Reviva Pharmaceuticals (RVPH)
| Year | EPS | Change |
|---|---|---|
| 2026 | -$0.25 | -92.61% |
| 2025 | -$3.38 | -73.33% |
| 2024 | -$12.68 | -54.91% |
| 2023 | -$28.12 | +1.75% |
| 2022 | -$27.64 | +134.13% |
| 2021 | -$11.81 | +2750.96% |
| 2020 | -$0.41 | -289.07% |
| 2019 | $0.22 | +103.40% |
| 2018 | $0.11 | N/A |